The magazine of the Air Liquide Group | Healthcare

Faced with the urgent need for ventilators to treat the patients most severely affected by COVID-19, Air Liquide, Groupe PSA, Schneider Electric, Valeo took up the challenge of producing 10.000 ventilators Air Liquide Medical Systems (ALMS) between April and mid-May, in response to a request from the French Government.

The increase in the number of chronic diseases,⁽¹⁾ new patient expectations, hospital overcrowding, and higher costs for treatment and its follow-up are major challenges for our healthcare systems. This new landscape provides an opportunity to collectively reinvent the patient pathway for chronically ill patients by focusing on personalized home care.

The stakes are high. With 425 million adults affected worldwide¹, diabetes is a pandemic. This chronic disease is ever-growing, and may affect as many as 629 million people by 2045². The intensive medical supervision required seriously hampers the daily habits and lifestyle of patients.

The healthcare industry is experiencing some major shifts, including aging populations, accelerated urban growth, technological progress, sedentary lifestyles, and the increase of chronic illnesses. Healthcare systems, which are often organized around hospitals, do not always encourage support for chronic diseases that require regular, long ­ term monitoring.

Healthcare is experiencing a revolution. Digital technologies have become an integral part of healthcare, transforming usages and economic models in ways that benefit patients and health professionals alike. In 2017, the innovative solution Chronic Care Connect™ has been developed in this environment undergoing major changes.

More than 4 billion people live on less than six dollars a day in developing economies. Proposing appropriate offers that are adapted to this BoP (Bottom of the Pyramid) market helps reduce poverty while building a win-win relationship. Spotlight on Access Oxygen, the new “inclusive” healthcare offer launched in Senegal.